Founder, President, and Chief Statistical Officer, John Balser, PhD, has been selected as a panellist and will be presenting in the scientific symposium: “Accelerate your Drug Development Program in Rare Disease with Robust Natural History Data: An Evolving Space” at 10:15 on Friday (5/19).
He is also a contributing author on the “Gene and Cell Therapy Trials in Progress” abstract that was accepted.
The ASGCT meeting takes place in Los Angeles, CA 16 May - 20 May 2023. Learn More >